PPARGC1A and metabolic dysfunction-associated steatotic liver disease: Therefore, we hypothesize that in the absence of PLIN5, a decrease in PGC-1α and possibly its downstream targets leads to reduced levels of CPT1 in Plin5−/− mice in NAFLD.